A spine fusion study found 61% success versus 17%. Providence now has a new titanium implant
Providence Medical Technology has announced FDA clearance for CORUS PCSS 3D-T, a porous titanium posterior cervical fusion implant. Its established platform has randomized clinical evidence, but the new implant's incremental clinical benefit remains to be demonstrated.
